TY - JOUR
T1 - Temporally and spatially resolved x-ray fluorescence measurements of in-situ drug concentration in metered-dose inhaler sprays
AU - Duke, Daniel J.
AU - Kastengren, Alan L.
AU - Mason-Smith, Nicholas
AU - Chen, Yang
AU - Young, Paul M.
AU - Traini, Daniela
AU - Lewis, David
AU - Edgington-Mitchell, Daniel
AU - Honnery, Damon
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Purpose: Drug concentration measurements in MDI sprays are typically performed using particle filtration or laser scattering. These techniques are ineffective in proximity to the nozzle, making it difficult to determine how factors such as nozzle design will affect the precipitation of co-solvent droplets in solution-based MDIs, and the final particle distribution. Methods: In optical measurements, scattering from the constituents is difficult to separate. We present a novel technique to directly measure drug distribution. A focused x-ray beam was used to stimulate x-ray fluorescence from the bromine in a solution containing 85% HFA, 15% ethanol co-solvent, and 1 μg / μL IPBr. Results: Instantaneous concentration measurements were obtained with 1 ms temporal resolution and 5 μm spatial resolution, providing information in a region that is inaccessible to many other diagnostics. The drug remains homogeneously mixed over time, but was found to be higher at the centerline than at the periphery. This may have implications for oropharyngeal deposition in vivo. Conclusions: Measurements in the dynamic, turbulent region of MDIs allow us to understand the physical links between formulation, inspiration, and geometry on final particle size and distribution. This will ultimately lead to a better understanding of how MDI design can be improved to enhance respirable fraction.
AB - Purpose: Drug concentration measurements in MDI sprays are typically performed using particle filtration or laser scattering. These techniques are ineffective in proximity to the nozzle, making it difficult to determine how factors such as nozzle design will affect the precipitation of co-solvent droplets in solution-based MDIs, and the final particle distribution. Methods: In optical measurements, scattering from the constituents is difficult to separate. We present a novel technique to directly measure drug distribution. A focused x-ray beam was used to stimulate x-ray fluorescence from the bromine in a solution containing 85% HFA, 15% ethanol co-solvent, and 1 μg / μL IPBr. Results: Instantaneous concentration measurements were obtained with 1 ms temporal resolution and 5 μm spatial resolution, providing information in a region that is inaccessible to many other diagnostics. The drug remains homogeneously mixed over time, but was found to be higher at the centerline than at the periphery. This may have implications for oropharyngeal deposition in vivo. Conclusions: Measurements in the dynamic, turbulent region of MDIs allow us to understand the physical links between formulation, inspiration, and geometry on final particle size and distribution. This will ultimately lead to a better understanding of how MDI design can be improved to enhance respirable fraction.
KW - fluorescence
KW - pressurized metered dose inhaler
KW - synchrotron radiation
KW - x-ray
UR - http://www.scopus.com/inward/record.url?scp=84960468642&partnerID=8YFLogxK
U2 - 10.1007/s11095-015-1828-6
DO - 10.1007/s11095-015-1828-6
M3 - Article
C2 - 26563204
AN - SCOPUS:84960468642
SN - 0724-8741
VL - 33
SP - 816
EP - 825
JO - Pharmaceutical Research
JF - Pharmaceutical Research
IS - 4
ER -